[Federal Register Volume 70, Number 249 (Thursday, December 29, 2005)]
[Notices]
[Page 77189]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E5-8082]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated June 8, 2005, and published in the Federal Register 
on June 15, 2005, (70 FR 34796), Boehringer Ingelheim Chemical Inc., 
2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances 
listed in Schedules II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
for formulation into finished pharmaceuticals. Subsequent to the Notice 
of Application, being published in the Federal Register on June 15, 
2005, Boehringer Ingelheim Chemical Inc., requested the surrender of 
drug code Levo-alphacetylmethadol (9648) from their registration.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Boehringer Ingelheim Chemical Inc. to manufacture the listed basic 
classes of controlled substances is consistent with the public interest 
at this time. DEA has investigated Boehringer Ingelheim Chemical Inc., 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823, and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: November 18, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. E5-8082 Filed 12-28-05; 8:45 am]
BILLING CODE 4410-09-P